Stryker (SYK) Cash from Operations Growth (3y) (2012 - 2026)
Stryker (SYK) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 0.50% |
| 10 | Steris | 21.55 Bn | 21.11 Bn | 697.10 Mn | 15.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.30% |
| Dec 31, 2025 | 28.80% |
| Sep 30, 2025 | 20.10% |
| Jun 30, 2025 | 28.06% |
| Mar 31, 2025 | 7.19% |
| Dec 31, 2024 | 24.53% |
| Sep 30, 2024 | 16.47% |
| Jun 30, 2024 | -10.33% |
| Mar 31, 2024 | -23.29% |
| Dec 31, 2023 | 7.30% |
| Sep 30, 2023 | 8.20% |
| Jun 30, 2023 | 3.53% |
| Mar 31, 2023 | -9.02% |
| Dec 31, 2022 | 10.92% |
| Sep 30, 2022 | 12.22% |
| Jun 30, 2022 | 0.96% |
| Mar 31, 2022 | -13.44% |
| Dec 31, 2021 | -1.49% |
| Sep 30, 2021 | 14.72% |
| Jun 30, 2021 | 10.60% |